Novolog vs. Apidra for Diabetes Type 2 and Diabetes Type 1: Important Differences and Potential Risks.

Key takeaways

Insulin aspart (NovoLog) and insulin glulisine (Apidra) are both rapid-acting insulins used to control blood sugar in people with type 1 and type 2 diabetes. NovoLog can be used in children as young as 2 years old, while Apidra is approved for children 4 years and older. NovoLog is typically injected 5 to 10 minutes before a meal, whereas Apidra can be injected within 15 minutes before or 20 minutes after starting a meal. Both medications are available in vials and prefilled pens, but Apidra can also be mixed with NPH insulin, which NovoLog cannot. Common side effects for both include low blood sugar and weight gain, but NovoLog has a higher reported rate of low blood sugar in type 1 diabetes (17%) compared to Apidra (7%). Both insulins need to be injected multiple times a day and come with similar storage requirements.

NovoLog

(insulin aspart)

Get free coupons

Apidra

(insulin glulisine)

Get free coupons

Summary for Novolog

Prescription only

NovoLog (insulin aspart) is a fast-acting insulin for adults and children with diabetes. It lowers your blood sugar levels by moving the sugar into your body so it can be used for energy. NovoLog (insulin aspart) is available as vials and ready-to-use prefilled pens. It's typically injected under the skin at mealtimes, but it can also be given as an infusion into the veins by a healthcare provider for people in the hospital. Side effects include headache and low blood sugar (hypoglycemia).

Indications for Novolog

Type 1 diabetes in adults and children
Type 2 diabetes in adults

Pros and Cons for Novolog

Pros

Starts to work within 10 minutes to lower blood sugar levels
Dose can be easily adjusted to make treatment tailored to your specific needs
Can use if you have liver or kidney problems
Available as a prefilled pen for easier and convenient use

Cons

Given multiple times per day (before each meal)
Must give as an injection
Might be hard for some people to inject properly
Risk of low blood sugar and weight gain

Common Side Effects for Novolog

Type 1 diabetes:

Severely low blood sugar (17%)
Headache (12%)
Accidental injury (11%)
Nausea (7%)
Diarrhea (5%)

Type 2 diabetes:

Muscles slow to react (11%)
Severely low blood sugar (10%)
Fungal nail infection (10%)
Impairment of your senses (9%)
Urinary tract infection (8%)
Sinus infection (5%)
Chest pain (5%)
Stomach pain (5%)
Headache (5%)
Skin problems (5%)

Warnings for Novolog

Spread of infections from sharing injection supplies
Low blood sugar (hypoglycemia)
Low blood potassium levels
Swelling from fluid buildup and risk of heart failure when taken with certain blood sugar medications
Dangerously high blood sugar levels or buildup of ketones (for people who use insulin pump)

Summary for Apidra

Prescription only

Insulin glulisine is a rapid-acting insulin that's available as a vial (Apidra) and a pre-filled pen (Apidra Solostar). It's used to control blood sugar from meals for people with either Type 1 diabetes (T1D) or Type 2 diabetes (T2D). Apidra (insulin glulisine) is given under the skin as either a quick injection or continuously through an insulin pump. It can also be given as an injection through the veins (IV) for people in the hospital. Side effects include low blood sugar (hypoglycemia) and common cold symptoms.

Indications for Apidra

Type 1 diabetes (T1D) in people ages 4 years and older
Type 2 diabetes (T2D) in people ages 18 years and older

Pros and Cons for Apidra

Pros

Works within 15 minutes to lower blood sugar
Available as a prefilled pen, which might be easier to use than the vial
Can be used with some insulin pumps
Can be mixed with NPH insulin (e.g., Novolin N), if instructed by your care team

Cons

Raises risk of dangerously low blood sugar levels
Given as an injection
Might need to inject multiple times a day
Might cause weight gain

Common Side Effects for Apidra

Type 1 diabetes

Common cold (11%)
Low blood sugar (up to 7%)
Upper respiratory tract infection (7%)
Headache (7%) - children only
Seizure from low blood sugar (6%) - children only
Flu (4%)

Type 2 diabetes

Upper respiratory tract infection (up to 11%)
Common cold (8%)
Swelling in the hands, ankles, or legs (8%)
Flu (6%)
Joint pain (6%)

Warnings for Apidra

Spread of infections from sharing injection supplies
Risk of high and low blood sugar levels
Dangerously low blood sugar levels (hypoglycemia)
Allergic reaction
Low blood potassium levels
Swelling from fluid buildup and risk of heart failure
Dangerously high blood sugar levels or buildup of ketones (for people who use insulin pump)